This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

News

New High Containment Packaging Facility at Ireland Site

Most recent EU acquisition and latest site to offer state-of-the-art contained packaging facility to global customers for potent compounds

Today, PCI Pharma Services premiered our new contained packaging facility for the primary and secondary packaging of highly potent products at our newly acquired site near Dublin, Ireland, EU. This latest investment further demonstrates our ability to provide current and future customers with the highest standards of excellence in outsourced pharmaceutical packaging services.

PCI is the recognized global leader in the manufacturing of highly potent molecules at the purpose-built, award-winning contained manufacturing facility located at our Tredegar site in Wales, UK. This latest investment in contained packaging capabilities at the PCI Ireland site ensures our ongoing commitment to delivering the highest standards of safety and regulatory adherence for specialized medicines. It is also the most recent part of our strategic initiative to develop our High Containment Operations (HCO) services globally.

“We are very excited to officially launch our state-of-the-art high contained packaging facility here in Ireland,” commented Bill Mitchell, President and CEO. “The recent acquisition of Millmount Healthcare and further investment in this newest specialized facility adds considerable capacity and capability to our global supply network, enabling us to meet our customers’ ever changing and evolving needs in many different geographies. Moreover, as our fourth acquisition outside the US in the past four years, this expansion further demonstrates our ability to provide our clients with a comprehensive solution to any uncertainty brought upon by ongoing negotiations between the UK and EU as a result of the evolving Brexit situation.

The Republic of Ireland has a thriving pharmaceutical and biotech community which PCI has been fortunate to support for many years. We have already received a tremendous response to the acquisition, and investments such as this high containment packaging facility are part of our strategic plan to continue business growth and service development for our customers. PCI is proud to provide services for medicines destined to over 100 countries around the world, and the Dublin site itself to more than 50 countries.

Since the acquisition of Millmount Healthcare, PCI has added approximately 30 positions at the Dublin area facilities and anticipates adding more than 100 positions over the next five years as the sites continue to expand and grow its operations.

PCI was supported in the planning and execution of its newest facility by IDA Ireland.

April 25, 2018


Salim Haffar to Join PCI Pharma Services as Chief Executive Officer

Bill Mitchell to Assume Role of Executive Co-Chairman PCI Pharma Services today announced that Salim Haffar will join the Company... View Article

New Serialization Installation at Tredegar

PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence Our Tredegar site is the latest to offer... View Article

x